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Bacteria will accompany humans in our exploration of space, making it of importance
to study their adaptation to the microgravity environment. To investigate potential
phenotypic changes for bacteria grown in space, Escherichia coli was cultured
onboard the International Space Station with matched controls on Earth. Samples were
challenged with different concentrations of gentamicin sulfate to study the role of drug
concentration on the dependent variables in the space environment. Analyses included
assessments of final cell count, cell size, cell envelope thickness, cell ultrastructure,
and culture morphology. A 13-fold increase in final cell count was observed in space
with respect to the ground controls and the space flight cells were able to grow in the
presence of normally inhibitory levels of gentamicin sulfate. Contrast light microscopy
and focused ion beam/scanning electron microscopy showed that, on average, cells in
space were 37% of the volume of their matched controls, which may alter the rate of
molecule–cell interactions in a diffusion-limited mass transport regime as is expected
to occur in microgravity. TEM imagery showed an increase in cell envelope thickness of
between 25 and 43% in space with respect to the Earth control group. Outer membrane
vesicles were observed on the spaceflight samples, but not on the Earth cultures. While
E. coli suspension cultures on Earth were homogenously distributed throughout the
liquid medium, in space they tended to form a cluster, leaving the surrounding medium
visibly clear of cells. This cell aggregation behavior may be associated with enhanced
biofilm formation observed in other spaceflight experiments.
Keywords: microgravity, bacterial growth, cell size, cell envelope, vesicle, aggregation, bioastronautics
INTRODUCTION
By default, bacteria will accompany humans in our exploration of space. The average healthy
individual carries trillions of microorganisms in and on their body, outnumbering human cells
(Sender et al., 2016). This human microbiome includes opportunistic pathogens, microbes that do
not normally cause disease in a healthy person but can provoke an infection when the person’s
immune system is suppressed, a concern known to occur during spaceflight (Borchers et al., 2002;
Mermel, 2013). It is therefore important to understand bacterial behavior in space in preparation
for future long-term human space exploration missions. Numerous prior studies performed in
space have shown increased bacterial virulence and decreased susceptibility to antibiotics for
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select in vitro cultures with respect to Earth controls (Tixador
et al., 1985, 1994; Lapchine et al., 1986; Moatti et al., 1986; Klaus
and Howard, 2006; Wilson et al., 2007, 2008; Parra et al., 2008;
Kitts et al., 2009; Ricco et al., 2010). While bacteria are generally
considered too small to be directly affected by the reduced gravity
of spaceflight (termed “microgravity” for being close to 10−6 g),
it is hypothesized that they are indirectly impacted by changes
in the fluid boundary layer surrounding the cell, as extracellular
mass transport becomes essentially limited to diffusion due to the
lack of gravity-driven convective flows (Klaus, 1994). Our group
recently published a related molecular genetic study indicating
that non-motile bacterial cells cultured in liquid medium in
space experienced a lack of substrates and increased acidity in
their local environment relative to the bulk fluid, which further
supports this altered extracellular transport model (Zea et al.,
2016).
To characterize related potential phenotypic changes to
bacteria cultured in the microgravity environment of spaceflight,
Escherichia coli was sent in stasis to the International Space
Station (ISS) and cultured for 49 h, with matched controls
maintained under 1 g conditions on Earth. Previous spaceflight
studies have presented mixed results in terms of phenotypic
expression, including altered envelope thickness and cell
aggregation (Zaloguyev et al., 1984; Tixador et al., 1985,
1994; Gasset et al., 1994; Menningmann and Heise, 1994;
Juergensmeyer et al., 1999). Based on these studies, it was
hypothesized that cells in space would present an increase in
cell envelope—which can have implications for drug resistance—
and would form aggregates in the absence of disrupting
sedimentation motion. Furthermore, it was hypothesized that, in
space, cells would grow in the presence of otherwise inhibitory
antibiotic concentrations. To test this, seven concentrations
of gentamicin sulfate (from 25 to 175 µg/mL in 25 µg/mL
increments) were added to E. coli cultures in space, but only
the three lowest concentrations were evaluated in Earth controls,
since it was already known that the normal minimum inhibitory
concentration was reached at this point under the ground
test conditions. Thus, this experiment was designed with two
independent variables: drug concentration, with no-drug samples
as controls, and gravitational regime, with Earth samples as
controls. The no-drug samples—both on Earth and space—were
requested to be fixed too early in the experiment, therefore their
data, while not completely lost as it provided insight into the
state of the cultures at drug introduction, did result in the loss
of the direct no-drug controls. However, the multiple data sets
still enable comparison of samples independently in each separate
gravitational regime as a function of varying drug concentration,
as well as comparison of the samples cultured in space with
respect to their matched Earth controls. Furthermore, Brown–
Forsythe and Welch’s statistical analyses indicated where it was
possible to aggregate data from samples with different drug
concentrations to enable space vs. Earth comparisons. This study
presents observations made in regards to changes in bacterial
growth, cell size, cell envelope thickness, cell ultrastructure, and
culture morphology observed in space with respect to matched
Earth controls, and as a function of varying drug concentration
in each environment.
MATERIALS AND METHODS
The experiment design, bacterial model, growth medium and
temperature, antibiotics, fixative, hardware, sample preparation
and loading, operational timeline, and cell count methodology
are described in detail in Zea et al. (2016), a related article from
the same study, and are summarized here. Briefly, 44 spaceflight
samples were used for the analysis reported in this manuscript.
Seven concentrations (25–175 µg/mL in 25 µg/mL increments)
of gentamicin sulfate (MP Biomedical, Cat No. 1676045,
Santa Ana, CA, United States) were assessed in quadruplicates
(7 × 4 = 28 samples). At the end of the experiment, samples
were fixed with a final 1.5% paraformaldehyde (PFA) (ACROS,
Cat. No. 41678, NJ, United States) solution in PBS (Fisher 506
Scientific, Cat. No. TA-125-PB, Waltham, MA, United States)
(pH 7.0) as fixative for post-flight phenotypic analyses. The
remaining 16 spaceflight samples had no antibiotic and were
used as controls. These sets were requested to be fixed too early
in the experiment to be used in the final cell count, but they
helped reveal cell concentrations at experiment start and at the
time of antibiotic introduction. Twenty Earth control samples
were used for the analysis reported in this manuscript. The
lowest three concentrations of gentamicin tested in space were
assessed on Earth in quadruplicates (3 × 4 = 12 samples).
The highest four concentrations were not prepared for the
Earth controls samples since it had already been determined
during pilot studies that bacterial growth was inhibited by this
point. Earth controls were also fixed with 1.5% PFA in PBS.
The remaining eight Earth samples contained no antibiotics
and were used as controls as described above. E. coli ATCC
4157 (non-motile) was used for this experiment, cultured in
Medium E minimal growth medium (Vogel and Bonner, 1956)
supplemented with 5g/L glucose (Fisher Scientific, Cat. No.
D-16, Waltham, MA, United States) at 30◦C, as this temperature
allows for a clearer differentiation of the growth phases (Kacena
et al., 1999; Klaus and Ahmed, 2010). Earth samples were
cultured statically (i.e., not shaken) to avoid introducing a
confounding factor. Spaceflight and Earth samples were cultured
in identical hardware and growth conditions: BioServe’s Fluid
Processing Apparatus (FPA) in Group Activation Pack (GAP)
(Hoehn et al., 2004). In space, they were inside the Commercial
Generic Bioprocessing Apparatus (CGBA) incubator as shown
in Figure 1. Cell count was measured with a hemocytometer
post-flight, as the reduction in cell size in space with respect
to Earth controls made the results from a plate reader
inaccurate.
Operational Timeline
The timeline for the preparation of the media and cultures,
integration of the samples into the Cygnus spacecraft, berthing
to the ISS and experiment activation is described in Zea (2015)
and Zea et al. (2016). The first experimental operation (t0) mixed
the inoculum with the growth medium contained in the FPA
(with the exception of the samples used to assess cell count at
this time where the inoculum was mixed with fixative). The
second operation, which occurred 19 h later (t1 = t0 + 19 h),
mixed the antibiotic solution with the bacterial culture (with the
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FIGURE 1 | NASA Astronaut Rick Mastracchio shown holding a GAP in his right hand and the crank used to perform an activation in the other as he performed the
experimental operations onboard the International Space Station. The open CGBA incubator loaded with other 15 GAPs is in the bottom right. Image: NASA. The
individual in this manuscript has given written informed consent to publish this image.
exception of the samples used to assess cell count at this time
where fixative was mixed with the culture instead of antibiotics).
The final operation occurred 30 h later (t2 = t1 + 30 h),
introducing the fixative into the bacterial culture. Thus, the total
incubation period, maintained at 30◦C, was 49 h. The protocols
were implemented identically for the space and matched Earth
sets.
Minimum Inhibitory Concentration for
Spaceflight Operations
The operational constraints associated with conducting
spaceflight research required incorporating a modified version
of the standard minimum inhibitory concentration (MIC)
protocol described by Andrews (2001). The pre-flight (1 g)
baseline MIC determination consisted of challenging an E. coli
inoculum in a dilution series of gentamicin sulfate using glass test
tubes that replicated the FPAs. After inoculating the antibiotic
dilution series, samples were incubated anaerobically for 32 h
and growth was assessed via photometry at that point. The MIC
was determined to be in between the lower drug concentration
where growth was still measured after incubation and the upper
concentration where no growth was observed. As indicated in
Supplementary Figures S1, S2, the MIC as tested was close to
20 µg/mL of gentamicin sulfate for the conditions specific to this
spaceflight experiment.
Statistical Analyses
Welch’s test is the statistical tool used to test the hypothesis
that two populations with unequal variances and samples sizes
have equal means (Welch, 1947). Because of this flexibility,
this statistical test was used to compare (a) cell growth in
space vs. Earth at the time of experiment start and (b) of
antibiotic introduction, (c) final cell count on the three lowest
drug concentrations, (d) cell length, (e) cell diameter, (f) cell
volume, and (g) cell envelope thickness on the two lowest
antibiotic concentrations, as all of these sets compared two
groups with unequal variances and sample sizes. Brown–Forsythe
is a statistical test that transforms the response variable allowing
to perform a one-way ANOVA on groups with unequal variances
(Brown and Forsythe, 1974). This test was chosen to assess
the role of drug concentration on cell (a) length, (b) diameter,
and (c) envelope thickness at each gravitational environment
(microgravity and 1 g), since these groups had different sample
sizes and variances.
Phase Contrast Microscopy and Cell
Size Measurements
Since the samples were already fixed in 1.5% PFA, no sample
preparation was required for microscopy, which was used
for analyzing cell and colony morphology, and cell length
and diameter. Samples were not centrifuged or otherwise
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manipulated prior to light microscopy. Phase contrast
microscopy was performed using a Carl Zeiss Axio Imager
M2 and a Nikon E600 Widefield Microscope. Cell length and
diameter data were acquired using ZEN (Zeiss, 2014) and
FIJI (LOCI, 2014) software. Cell length and diameter data
were acquired only from cells with their axis coplanar to the
microscopy image, i.e., only of cells that were “lying flat” with
respect to the image. Cell volume was calculated by modeling a
bacterial cell as a cylinder with two hemispheres.
Transmission Electron Microscopy
Following centrifugation, the supernatant was replaced and
the sample pellets re-suspended and rinsed in 0.15 M sodium
cacodylate buffer (pH 7.2), three times. Next, the sample pellets
were embedded in low-melting point agarose and postfixed in
1% w/v OsO4 in 0.12 M sodium cacodylate buffer (pH 7.2)
for 2 h. The specimens were dehydrated in graded series of
ethanol, transferred to propylene oxide and embedded in Epon
according to standard procedures. Sections, approximately 80 nm
thick, were cut with a Leica Ultra microtome UC7 and collected
on copper grids with Formvar supporting membranes, stained
with uranyl acetate and lead citrate, and subsequently examined
with a Philips CM 100 TEM (Philips, Eindhoven, Netherlands),
operated at an accelerating voltage of 80 kV. Digital images were
recorded with an OSIS Veleta digital slow scan 2k × 2k CCD
camera (Olympus, Germany) and the ITEM software package.
Focused Ion Beam/Scanning Electron
Microscopy
The Epon embedded specimens were placed in a Dual-Beam
microscope (Quanta FEG 3D FIB-SEM, FEI, Netherlands)
equipped with a gallium ion source for milling and a dedicated
backscattered electron detector for imaging (vCD). The surface of
the block and the trimmed edge was located with the secondary
electron detector in standard SEM mode with definition of an
area of interest. For focused ion beam milling the block was tilted
to 52◦ and the edge of the block aligned at eucentric height,
followed by crossover alignment of both electron and ion beams.
The ion beam was used in conjunction with a gas injection system
to deposit a 1 µm layer of platinum on the top surface of the
sample, above the region of interest to reduce milling artifacts.
Next, trenches approximately 6 µm wide were milled at high
beam current on both sides of the region of interest to avoid
deposition artifacts. The G2 Slice and View software (FEI) was
used for automatic milling and image recording with automatic
refocusing of the exposed surface.
3D Image Reconstruction
Digital image datasets were recorded from the sample blocks
containing space flight 25 µg/mL (790 images) and Earth control
25 µg/mL sets (748 images). The images with the specifications
of 2048× 1768 pixels in 8 bits were assembled and automatically
aligned in Amira 6.0.0—ResolveRT. Voxel size was x = 6.7 nm,
y = 8.5 nm, and z = 30 nm. From the two image stacks, all
bacteria were automatically masked using the LabelField and
all well-fixed and non-edematous bacteria were included for 3D
reconstruction. Identical mask parameters for the two samples
were manually set in the masking dialog. 3D models were
generated by the SurfaceGen and projected by the SurfaceView.
Finally, the images were captured in high resolution and post-
produced in Photoshop CC.
RESULTS
Bacterial Growth
Cell concentration in the spaceflight and Earth control samples
was measured post-flight via hemocytometer count by fixing
samples at three different time points in the experiment: (1)
start (inoculation), (2) acceleration phase (in between lag and
exponential phases, when the antibiotic was introduced), and
(3) at the end of the test (stationary phase). The spaceflight
and Earth cell counts were compared with Welch’s tests
since they had different sample sizes and variances. No
statistically significant difference was observed in cell count
at experiment start (Mspace = 3.75 × 105 cell/mL, SEspace =
1.34 × 105 cell/mL, nspace = 8; MEarth = 1.25 × 105 cell/mL,
SEEarth = 7.22 × 104 cell/mL, nEarth = 4) or acceleration phase
(Mspace = 6.9 × 106 cell/mL, SEspace = 2.8 × 106 cell/mL,
nspace = 8; MEarth = 7.9 × 106 cell/mL, SEEarth =
8.3 × 105 cell/mL, nEarth = 4) in between spaceflight and
matching Earth controls. Spaceflight cell concentrations at
the end of the experiment, however, were higher than their
respective Earth controls in all cases. When challenged with
25 µg/mL of gentamicin sulfate, there was a sevenfold increase
in final cell count on spaceflight with respect to Earth [Welch’s
F(1,4.82) = 156.83, p < 0.001]. This increase was 41-fold
[Welch’s F(1,2.37) = 300.69, p < 0.01] and 18-fold [Welch’s
F(1,3.07) = 32.96, p < 0.05] for the next two antibiotic
concentrations (50 and 75 µg/mL), respectively. Conducting
a Welch’s test on these three lowest concentrations as a single
group showed that there was a 13-fold increase in final cell count
in space with respect to Earth [Welch’s F(1,10.88) = 116.68,
p < 0.0001]. Figure 2 describes the differences in cell count in
space (black bars) with respect to Earth controls (gold bars),
and as a function of drug concentration in each gravitational
environment. A Welch’s test conducted to evaluate growth from
the time of antibiotic introduction until fixation showed that the
flight samples achieved a significant increase in cell count at the
lowest three drug concentrations (25, 50, and 75 mg/mL), while
the corresponding ground controls did not exhibit any statistical
growth difference in that timeframe.
Cell Size
Cell size measurements were taken from all samples using
contrast light microscopy. The paired cell length and diameter
data of each measured bacterium was used to calculate cellular
volumes independently. Because sample sizes and variances
differed among samples, Brown–Forsythe tests were conducted
to assess the role of drug concentration on (a) cell length and
(b) diameter at each gravitational environment (microgravity
and 1 g). It was concluded that neither cell length nor
cell diameter were dependent upon drug concentration in
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FIGURE 2 | Escherichia coli growth challenged with gentamicin sulfate. Black bars represent spaceflight; gold bars are Earth samples. The gray and blue lines
indicate the cell concentration at the time of antibiotic introduction in space and Earth, respectively, showing the average (center line) and standard errors (upper and
lower lines). Spaceflight cultures showed higher cell counts than their Earth matched controls (13-fold increase in average). Although there appears to be a decrease
in magnitude at 150 and 175 µg/mL with respect to 125 µg/mL, this is misleading as accurate values were hard to acquire either by cell count or optical density due
to cell aggregation in these samples. It is estimated that values at 150 and 175 µg/mL were roughly equivalent to that of 125 µg/mL. Bars indicate standard error;
n = 4 for all except for spaceflight at 25 and 50 µg/mL (n = 3, each), and 175 µg/mL (n = 2), as only the samples for which it was certain that the antibiotic was fully
introduced were considered. ∗p ≤ 0.05, ∗∗p ≤ 0.01, and ∗∗∗p ≤ 0.001.
space [length: Welch’s F(6,17.92) = 2.03, p = 0.12; diameter:
Welch’s F(6,32.48) = 1.78, p = 0.14] or on Earth [length:
Welch’s F(2, 8.71) = 1.73, p = 0.24; diameter: Welch’s
F(2,16.52) = 3.46, p = 0.06], which enables comparison of
cell size values acquired from space as a collective data set
to those from Earth as another data set (Figure 3). Two
Welch’s tests were performed to determine if the gravitational
environment had an impact on cell length or cell diameter.
It was found that, in space, cells averaged 59% the length
and 83% the diameter of the Earth controls (see Table 1).
Thus, on average, cells in space were smaller at 37% of the
volume of the Earth controls, as indicated in Figure 3. Focused
ion beam/scanning electron microscopy (FIB/SEM) analyses
corroborated the observed reduction in size on cultures grown
in space (Figure 4).
Cell Envelope Thickness
Cell envelope thickness data was acquired via transmission
electron microscopy (TEM). Measurements were acquired for
all seven gentamicin concentrations in space (n = 585) and
for the two lowest concentrations on Earth (n = 67). The
results showed that envelope thickness varied as a function
of drug concentration both in space and on Earth [Brown–
Forsythe: F(6,508.19)= 22.08, p< 0.0001 and F(1,26.46)= 5.52,
p < 0.05, respectively). On average, the cells challenged with
25 µg/mL of antibiotics in space had cell envelopes that were
25% greater than the thickness of their matched Earth controls
[Welch’s F(1,112.98) = 40.75, p < 0.0001; Mspace = 24.76 nm,
SDspace = 4.55 nm, nspace = 64; MEarth = 19.87 nm,
SDspace = 3.67 nm, nEarth = 51]. Similarly, the cells challenged
with 50 µg/mL of antibiotics in space had cell envelopes 43%
greater than the thickness of their matched Earth controls
[Welch’s F(1,23.08) = 59.75, p < 0.0001; Mspace = 24.97 nm,
SDspace = 3.80 nm, nspace = 78; MEarth = 17.51 nm,
SDspace = 3.46 nm, nEarth = 16] as described in Figure 5.
It was not possible to acquire cell envelope data from the
75 µg/mL Earth controls due to the low cell concentrations
available in the aliquots from those samples used for this
analysis.
Cell Ultrastructure—Vesicle Formation
As seen in Figure 6, outer membrane vesicle (OMV) formation
was observed in space, especially at the highest concentrations of
gentamicin (175 µg/mL). No OMV formation was observed on
the Earth samples, as shown in Supplementary Figure S3.
Bacterial Culture Morphology—Cell
Aggregation
From initial qualitative assessment of the samples upon their
return to Earth, pronounced cell aggregation was the most
prominent phenomenon observed. Spaceflight samples with
gentamicin sulfate concentrations of 125 µg/mL or higher
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FIGURE 3 | In space, E. coli cells were 59% the length, 83% the diameter, and thus 37% the volume of Earth controls. Bars indicate standard error; n = 133 and 31
for spaceflight and Earth, respectively. ∗∗∗∗p ≤ 0.0001.
TABLE 1 | Results and statistics of cell length, diameter, and volume of spaceflight and Earth samples; nspace = 133 cells, nEarth = 31 cells.
Space Earth Space wrt Earth Statistical test p
Length M = 1.684 µm, SD = 0.319 µm M = 2.838 µm, SD = 0.644 µm 59% Welch’s F (1,33.51) = 94.24 <0.0001
Diameter M = 0.638 µm, SD = 0.090 µm M = 0.773 µm, SD = 0.138 µm 83% Welch’s F (1,36.13) = 26.95 <0.0001
Volume M = 0.481 µm3, SD = 0.170 µm3 M = 1.295 µm3, SD = 0.632 µm3 37% Welch’s F (1,31.02) = 50.53 <0.0001
FIGURE 4 | Focused ion beam/scanning electron microscopy (FIB/SEM) image of samples challenged with 25 µg/mL gentamicin: spaceflight (left) and Earth control
(right). FIB/SEM analysis corroborated the findings on reduced cell size in space. Scale bar on axes = 500 nm.
exhibited cell aggregation to the point that the culture essentially
became a contiguous, single cluster as seen in Figure 7. This
behavior was not observed in the Earth controls and is in stark
contrast to the usually uniform fine turbidity cultures observed
in 1 g. Phase contrast microscopy shows these results more clearly
(Figure 8).
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FIGURE 5 | In space, cell envelope thickness increased by 25 and 43% in the
25 and 50 µg/mL samples, respectively. Bars indicate standard error; n = 585
and 67 for spaceflight and Earth, respectively.
DISCUSSION
Bacterial Growth
No statistically significant difference was observed in the
cell population counts that were fixed immediately following
inoculation or during the acceleration phase between the
spaceflight and Earth cultures. This indicates that the results
observed in this experiment are not a result of different starting
cell concentrations, and that the initial ratio of antibiotic
molecules per bacterium was consistent between spaceflight and
Earth controls, respectively. Although the lack of significant
difference in cell count during the acceleration phase could
also suggest that no changes occurred in lag phase duration,
data from only one point in time is insufficient to make
such claim, as this does not determine when the acceleration
phase actually started. Zea et al. (2016) provided molecular
genetic evidence of the “altered extracellular environment” model
explaining altered bacterial behavior in space, which would
FIGURE 7 | E. coli commonly grows with uniform fine turbidity as seen in the
25 µg/mL Earth control (upper image). Spaceflight samples challenged with
the concentrations of gentamicin at 125 µg/mL or higher tended to
aggregate. The lower image shows the spaceflight sample treated with
175 µg/mL—after its return to Earth—and the clustered cells (red box) in an
otherwise visibly clear growth medium.
also suggest that quorum sensing molecules may accumulate
around the cells and only dissipate to the bulk fluid via
diffusion. This may explain the decrease in lag phase duration
observed in some spaceflight experiments described by Horneck
et al. (2010), which will be discussed in more detail in
a separate manuscript. Spaceflight cell concentrations at the
end of the growth period were always higher than their
respective Earth controls (13-fold increase on average), which
FIGURE 6 | Thin-section transmission electron microscopy (TEM) images of E. coli. Left: sample cultured on Earth and challenged with 50 µg/mL gentamicin. Right:
sample cultured in space and challenged with 175 µg/mL shows the presence of extracellular vesicles (red arrows) and irregular cellular shapes. Images taken with a
Philips CM 100 TEM at an accelerating voltage of 80 kV.
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FIGURE 8 | Phase contrast images of E. coli cultured on Earth (upper image)
and in space (lower image), the latter exhibiting cell aggregation. The upper
image shows an Earth control sample challenged with the lowest
concentration of gentamicin sulfate (25 µg/mL) and the lower a spaceflight
sample treated with the highest concentration of the same drug at
175 µg/mL. The differences in cell size are also noticeable here. Images taken
with a Nikon E600 Widefield Microscope.
was expected based on previous spaceflight observations (as
reviewed in Horneck et al., 2010). Furthermore, as statistically
indicated in the results, the flight cells were able to grow
in the presence of normally inhibitory levels of gentamicin
sulfate.
Cell Size
The average volume of the spaceflight cells was 37% of the
Earth controls. The reduction in volume, and therefore surface
area and cross-section, translates into a lower probabilistic rate
of diffusion-driven molecule–cell interactions. This reduction
in contact area is in addition to the presumed altered
extracellular environment, which further suggests that molecule–
cell interactions will differ in space compared to Earth (Zea,
2015; Zea et al., 2016). The decreased cell size observed in
this experiment is in contrast, albeit for different species, with
what was reported by Pyle et al. (1999), who noted elongated
Burkholderia cepacia cells (and chains of cells) in the spaceflight
cultures, and with Wilson et al. (2007), who did not see any
differences between spaceflight and Earth control Salmonella
typhimurium cell size or shape. However, both of these strains
were motile, and Benoit and Klaus (2007) have already shown
a correlation between motility and a potential disruption of
the quiescent extracellular environment, thereby eradicating the
ensuing proposed effects. Since the E. coli strain used in this
experiment was non-motile, this suggests that the decrease in
cell size may have been a result of extracellular environment
factors reducing glucose exposure and increasing acidic level.
This is similar to results reported by Jubair et al. (2012), where
persister cells from Vibrio cholerae exposed to a nutrient-poor
condition presented morphologies that were very small in size
and with a high degree of aggregation. A decrease in cell size
in microgravity has also been reported for a fungal organism:
Candida albicans. Crabbé et al. (2013) determined that C. albicans
cultured in space had 70% of the surface area of their matched
Earth controls, that they showed a 3D organization (opposite
to the flat appearance of Earth samples), and that aberrant
forms were observed in space while in 1 g, they presented a
rounder morphology. This observed decrease in cell size also
warrants revisiting mathematical and computational models
used to simulate the altered extracellular environment in space,
as these earlier efforts assumed that cells were the same size
as on Earth (Klaus et al., 1997, 2004; Benoit, 2005; Benoit
et al., 2008). Interestingly, as noted by Nanninga (1985), faster
growing E. coli cells, under certain conditions, were shown
to increase in mass. Klaus (1994) suggested—based on optical
density data—that E. coli in space experienced a slower rate
of growth (albeit for a longer duration of time), which was
further discussed by Brown (1999). Therefore, the observed
decrease in cell size may also be related to a change on growth
rate.
Cell Envelope Thickness
The two experimental sets that could be directly compared
indicate that E. coli samples cultured in space exhibited an
increased cell envelope thickness with respect to their matched
Earth controls. This investigation follows at least four spaceflight
experiments in which changes to cell envelope thickness have
been assessed. The first investigation concluded (although
no statistical analyses were presented) that there were no
differences in envelope thickness of E. coli, but there were on
Staphylococcus aureus (Zaloguyev et al., 1984; Tixador et al.,
1985). Three other studies also reported no changes occurred
in cell envelope for E. coli (Gasset et al., 1994; Tixador et al.,
1994) or Bacillus subtilis (Menningmann and Heise, 1994),
nor were any differences noted in cell structure in general
for E. coli, B. subtilis, or S. aureus (Juergensmeyer et al.,
1999). However, none of these investigations report statistical
significance in their analyses, and from all four only one
(Gasset et al., 1994; Tixador et al., 1994) reported having fixed
the samples in space. In other words, the first three studies
measured the cell envelope of cultures that had potentially
already re-adapted post-flight to 1 g before the samples were
processed (Zea, 2015); thus, no appropriate prior spaceflight
phenotype is available against which to directly compare our
current findings. Interestingly, a thickened cell envelope has been
associated with drug-resistant bacterial strains. For example, Raju
et al. (2007) and Fukutsuji et al. (2013) separately concluded
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that gentamicin-resistant S. aureus strains showed a thickened
cell wall. Similarly, Yuan et al. (2013) showed that amikacin
(another aminoglycoside-class antibiotic) resistant methicillin-
resistant S. aureus presented a thickened cell wall, concluding
that this phenotypic phenomenon is associated with adaptive
resistance. Nevertheless, no systematic studies on E. coli’s cell
envelope increase due to aminoglycosides were found in the
literature.
Cell Ultrastructure—Vesicle Formation
Qualitative observations made on the TEM imagery showed
the presence of OMVs on the spaceflight samples treated
with 75 µg/mL or higher concentrations of gentamicin—with
more OMVs observed at the highest concentration tested,
175 µg/mL, but not on the Earth samples. While Figure 6
shows the difference in OMVs between spaceflight and Earth
samples, it is acknowledged that these cannot be directly
compared as they represent two different drug concentrations.
However, it conveys the observations of OMV formation
in space—and not on Earth—and especially at higher drug
concentrations. OMVs contain proteins that play a role in
the delivery of toxins during infection, biofilm nucleation,
defense against antimicrobials, nutrient acquisition, and DNA
transfer (Kulp et al., 2015), and are especially helpful in the
transport of hydrophobic signaling (quorum sensing) molecules
(Mashburn and Whiteley, 2005). Collins (2011) also showed that
OMVs can be advantageous coaggregation in biofilm formation.
Manning and Kuehn (2011) showed that OMVs can adsorb
compounds that act on the cellular outer membrane, including
antimicrobial peptides, and hypothesized that vesiculation is
a quick response to low doses of stressors before resistance
mechanisms can be activated. Kulp et al. (2015) suggested that
in wildtype E. coli, incomplete lipopolysaccharides structures
yielded more OMVs, and that vesiculation levels were inversely
proportional to enterobacterial common antigen chain length.
McBroom and Kuehn (2007) showed that vesiculation is an
independent stress response that enhances bacterial survival
rates by allowing them to export stress products—such as
damaged or misfolded proteins—and that it is regulated
by the level of protein accumulation in the envelope. The
observed formation of OMVs at highest concentrations of
drug in space, where transport is limited, may indicate that
cells were exposed to what on Earth would be considered
a “low dose” of drug, which elicited the activation of
resistance mechanisms. The low-dose activation under a high-
dose environment in space may be an artifact of the altered
extracellular environment described by Zea et al. (2016), where
a lower rate of drug molecule–cell interaction—exacerbated by
a decrease in cell size—was experienced in the microgravity
environment.
Bacterial Culture Morphology—Cell
Aggregation
While the Earth and space images on Figures 7, 8 are not meant
to be directly compared—as they represent two different drug
concentrations—they convey the qualitative observation of cell
aggregation on the spaceflight samples with respect to Earth
cultures, especially at higher drug concentrations in space. This
qualitative data may also serve as a basis for future quantitative
studies. This cell clustering observed on the spaceflight samples
is in agreement with previous microgravity studies. Wilson
et al. (2007) reported that S. typhimurium cultured in space
exhibited clear differences in cell aggregation and clumping,
which they saw was associated with an extracellular matrix
accumulation consistent with biofilm formation. Crabbé et al.
(2013) reported C. albicans aggregation, enhanced random
budding (as opposed to the bipolar budding observed on
the Earth samples) and a concomitant differential expression
of the genes in this organism’s main flocculation regulatory
pathways. On the other hand, Kim et al. (2013) did not
observe cell clustering on Pseudomonas aeruginosa cultured
in space, which they suggested was likely due to differences
in the extracellular polymeric substances of the strain they
used for their test. Similar results of cell aggregation have
been documented from simulated microgravity tests with
different model organisms. Self-aggregative biofilm phenotypes
of bacterial cultures (S. aureus and P. aeruginosa) were also
reported after growth in rotating wall vessels (Crabbé et al.,
2008; Castro et al., 2011). Fungal cultures (Saccharomyces
cerevisiae) have displayed increased cell clumping under
simulated microgravity (Purevdorj-Gage et al., 2006). Similarly,
algal (Chlorella pyrenoidosa) cell aggregation was observed to
increase as a function of time during simulated microgravity [the
clumping reported by Mills and Pierson (2003) was strikingly
similar to Figure 8]; in this case, the authors concluded that
the basis for, or significance of this clumping was unknown
(Mills and Pierson, 2003). The observed increase in flocculation
or cell clustering in space may facilitate conjugation (genetic
recombination), which was reported in an early spaceflight
bacterial study by Ciferri et al. (1986). The increased cell
aggregation of bacteria and fungi observed in space, and
its association with biofilm formation and potentially with
enhanced conjugation, may therefore present deleterious effects
for long-term human spaceflight and warrant further studying of
these phenomena.
CONCLUSION
A 13-fold increase in final cell count in space was observed
with respect to Earth without any statistically significant
differences in cell population count at inoculation or when
the drug was introduced. This indicates that the higher
final cell count achieved in space under normally inhibitory
levels of gentamicin sulfate was not an artifact of different
starting cell concentrations or cell/antibiotic molecule ratio
between Earth and space. Contrast light microscopy and
FIB/SEM showed that, on average, cells in space were
37% of the volume of their matched Earth controls. The
resultant decrease in surface area and cross section may
reduce the rate of molecule–cell interactions in a diffusion-
dominated mass transport regime, as is expected to occur in
microgravity. This reduction in cellular volume is consistent with
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other studies where bacteria have been cultured in substrate-
poor environments providing further support to the altered-
extracellular environment model believed to occur in space (Zea
et al., 2016). TEM imagery showed an increase in cell envelope
thickness between 25 and 43% in space with respect to Earth.
OMVs were observed on the spaceflight cells, especially in the
higher drug concentrations cases, but were not seen on the Earth
cultures. Both the increase in cell envelope thickness and in OMV
formation may be indicative of drug resistance mechanisms
being activated in the spaceflight samples. While E. coli cultures
on Earth were homogenously distributed in the liquid medium
through the growth phases, in space they tended to form a
single cluster leaving the rest of the medium visibly clear of cells.
This cell aggregation may be associated with enhanced biofilm
formation reported on other spaceflight experiments and needs
to be studied further to determine the cause and significance.
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FIGURE S1 | A 2 × 107 cell/mL inoculum of E. coli was challenged in a
gentamicin sulfate dilution series ranging from 80 to 200 µg/mL, and incubated
anaerobically for 32 h at 30◦C in glass test tubes to replicate the FPAs. The blue
boxes indicate the cell concentration at the time of experiment start
(2–3 × 107 cell/mL), centered at the average and covering two standard errors in
height. While bacterial growth was observed in the no-drug control, no growth
was observed as of 80 µg/mL, suggesting the as-tested MIC was between 0 and
80 µg/mL of gentamicin sulfate.
FIGURE S2 | A 3 × 107 cell/mL inoculum of E. coli was challenged in a
gentamicin sulfate dilution series ranging from 10 to 40 µg/mL, and incubated
anaerobically for 32 h at 30◦C in glass test tubes to replicate the FPAs. The blue
boxes indicate the cell concentration at the time of experiment start
(3 × 107 cell/mL), centered at the average and covering two standard errors in
height. While bacterial growth was observed when challenged with 10 µg/mL and
some was debatable at 20 µg/mL, no growth was measured as of 30 µg/mL,
suggesting the as-tested MIC was close to 20 µg/mL of gentamicin
sulfate.
FIGURE S3 | Thin-section transmission electron microscopy (TEM) images of
E. coli cultured in space, showing no outer membrane vesicle formation at lower
drug concentrations (25 µg/mL gentamicin on left, 50 µg/mL gentamicin on
center), and multiple (OMVs) at 175 µg/m (right). Images taken with a Philips CM
100 TEM at an accelerating voltage of 80 kV.
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